Clinical Trial Update: Safety/Efficacy of a Vaccine Prepared From Dendritic Cells Combined With Tumor Cells to Treat Advanced Kidney Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluates safety and preliminary efficacy of a vaccine made from dendritic cells combined with tumor cells for advanced renal cell ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Dendritic cell-tumor cell vaccine (dendritic cell-tumor cell vaccine)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Carcinoma, Renal Cell | Phase 1, Phase 2 | Status: COMPLETED